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Abstract
While the use of acupuncture has been recognised by the World Health Organisation, its
efficacy for many of the common clinical conditions is still undergoing validation through
randomised controlled trials (RCTs). A credible placebo control for such RCTs to enable
meaningful evaluation of its efficacy is to be established. While several non-penetrating
acupuncture placebo devices, namely the Streitberger, the Park and the Takakura Devices,
have been developed and used in RCTs, their suitability as inert placebo controls needs to
be rigorously determined. This article systematically reviews these devices as placebo
interventions. Electronic searches were conducted on four English and two Chinese data-
bases from their inceptions to July 2014; hand searches of relevant references were also
conducted. RCTs, in English or Chinese language, comparing acupuncture with one of the
aforementioned devices as the control intervention on human participants with any clinical
condition and evaluating clinically related outcomes were included. Thirty-six studies were
included for qualitative analysis while 14 were in the meta-analysis. The meta-analysis
does not support the notion of either the Streitberger or the Park Device being inert control
interventions while none of the studies involving the Takakura Device was included in the
meta-analysis. Sixteen studies reported the occurrence of adverse events, with no signifi-
cant difference between verum and placebo acupuncture. Author-reported blinding credibil-
ity showed that participant blinding was successful in most cases; however, when blinding
index was calculated, only one study, which utilised the Park Device, seemed to have an
ideal blinding scenario. Although the blinding index could not be calculated for the Takakura
Device, it was the only device reported to enable practitioner blinding. There are limitations
with each of the placebo devices and more rigorous studies are needed to further evaluate
their effects and blinding credibility.
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Introduction
The use of acupuncture dates back as far as 1700BC from ancient China [1] and is currently an
internationally used treatment option. In 2003, the World Health Organisation published a
review and analysis of clinical controlled trials on acupuncture for a number of conditions [2]
and recently there has been increasing attention in researching acupuncture needles [3–5].
Despite the frequent and wide utilisation, clinical trials have yielded conflicting results regard-
ing the benefit of acupuncture [6]. There is a need for scientifically rigorous studies to evaluate
the theoretical basis for acupuncture [7].
RCTs are considered the “gold standard” of evaluating the efficacy of an intervention. With
regard to acupuncture RCTs, several types of control interventions have been used. These
include 1). sham acupuncture, which involves skin penetration using the needles, either shal-
lowly or on non-acupuncture points; 2). placebo acupuncture, which involves non-penetrating
placebo acupuncture devices; 3). pseudo stimulation, such as transcutaneous electrical nerve
stimulation (TENS) or laser acupuncture; and 4). other therapies or no treatment [8,9].
Placebo-controlled studies needed to evaluate the efficacy of interventions. The ideal pla-
cebo control should be inert to enable the differentiation between the specific effects and non-
specific effects of an intervention [10], yet indistinguishable from the real intervention to allow
blinding of both practitioners and participants of RCTs as well as those involved in data gather-
ing and analysis. However, when it comes to complex physical interventions such as acupunc-
ture establishing an appropriate placebo-control intervention has been a major barrier as it is
difficult to determine whether the so called “placebo” is fully inert. Sham and placebo needling
have been two of the most commonly used forms of placebo-control in acupuncture studies.
However, with the former, there is an on-going debate on its appropriateness as an inert con-
trol [11] as there have been studies suggesting the possibility of physiological responses elicited
by skin penetration of the sham intervention [12]. To address the challenges of placebo control
methods, researchers have also developed a number of non-penetrating placebo acupuncture
devices. The first device, commonly known as the Streitberger Device, was introduced by Streit-
berger and Kleinhenz in 1998 [13]. The Streitberger Device uses a blunt-tipped needle with a
shaft that telescopes into the copper handle of the needle, allowing the production of a pricking
sensation when the needle touches the skin but without skin penetration. However, the Streitber-
ger Device is said to be potentially unsuitable for certain areas of the body, does not allow for
diversity in manual stimulation or needling direction and the sterilisation of needles may be com-
promised as the needle penetrates through the dressing plaster [14,15]. The Park Device was
introduced shortly after and attempted to improve the design [16]. It includes a blunt-tip tele-
scope needle within a standard guide tube, and a sheath (Park tube) with a flange connected at
one end to maintain the sterilisation. The device is secured to the skin with double sided sticky
tape. However, both the Streitberger Device and the Park Device do not allow for double-blind-
ing. The Takakura Device was introduced in 2007 [17]. This device also utilises a blunt-tipped
needle that touches but does not penetrate the skin; and a stopper is added to limit the depth of
needle insertion to create a similar appearance to a penetrating needle. There is also added soft
material stuffing in the guide tubes of the device to generate a similar feeling by practitioners dur-
ing needling. The Takakura Device was the first acupuncture placebo device that was designed to
enable the blinding of both practitioners and participants. Fig 1 presents these three devices.
While there are several other non-penetrating placebo acupuncture devices available [18–
21], the above three have been the most widely used and validated in multiple RCTs. Currently,
there has yet to be a comprehensive systematic review investigating whether these devices fulfil
the requirements of being inert placebo controls in RCTs for different conditions. This article
will fill the important knowledge gap by systematically reviewing RCTs of acupuncture which
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utilised one of these three placebo acupuncture devices, with the primary aim to evaluate their
validity as an inert placebo intervention, from the points of view of minimising therapeutic
effects and successful blinding. The results from this study may enable the comparison between
the three placebo acupuncture devices, support further study into what makes a credible pla-
cebo acupuncture device and potentially lead to the development of a better form of acupunc-
ture control intervention for future RCTs.
Methods
Search strategies
Electronic searches were carried out on four English databases (CINAHL, Cochrane Library,
Embase, PubMed) and two Chinese databases (VIP Database for Chinese Technical Periodicals
Fig 1. PRISMA flow diagram of study selection process.
doi:10.1371/journal.pone.0140825.g001
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(CQVIP) and China National Knowledge Infrastructure (CNKI)) from their inceptions to July
2014. The search terms applied were in three groups: acupuncture, RCT, and placebo/sham.
Search terms used in Pubmed search is provided as in supplementary file (S1 Table) as an
example. Hand searches of references of relevant articles and publication lists of the key
authors (Streitberger, Park, Takakura, and their co-authors in this field) were also conducted.
Study selection criteria
Published RCTs, in English or Chinese language, comparing manual acupuncture with the
Streitberger Device, the Park Device or the Takakura Device as the control intervention on
human participants with any clinical condition and evaluating clinically related outcomes were
included in this review. Since the purpose of this review is to evaluate the placebo devices, we
did not place any limitation on the clinical conditions and their outcome measures. However,
studies which modified the placebo acupuncture devices or did not apply the device as it was
designed were excluded. Studies were also excluded if sham points were adopted in placebo
acupuncture control groups in addition to placebo device. Finally, although electroacupuncture
is one of the most frequently used methods in acupuncture clinical trials, the distinction or
added-on effect from electric stimulation in electroacupuncture is unclear. Therefore, studies
which applied techniques other than manual acupuncture, such as TENS, electroacupuncture
or laser acupuncture were excluded to minimise confounding factors.
Data Extraction and Risk of Bias Assessment
The publication year, disease or condition studied, participants’ demographic data, methodo-
logical characteristics, treatment protocol, clinically relevant outcomes, and evaluation of
blinding, if available, were extracted from included studies onto an Excel spread sheet by two
reviewers (HYT and CSZ) and crosschecked. For multiple armed studies, only data of the rele-
vant interventions were extracted. Assessment of risk of bias was conducted using the
Cochrane Collaboration’s tool for assessing risk of bias [22]. Any disagreement was resolved
via discussion.
Data Analysis
Cochrane Review Manager (RevMan 5.3) software was used for statistical analysis. Post-treat-
ment outcome data were selected for data analysis. If sufficient data were present, pooled analy-
sis was conducted, with subgroup analysis for each of the placebo acupuncture device.
Dichotomous data were reported as risk ratio (RR) with 95% confidence intervals (CI), and
continuous data were reported as mean difference (MD) with 95% confidence intervals (CI),
where the outcomes were measured in the same way between trials. For trials reporting the
same outcome measures but which used different methods, the standardised mean difference
(SMD) was reported. The success of blinding was evaluated using the blinding index (BI) devel-
oped by Bang et al. where possible [23].
The PRISMA checklist is available as supplementary file (S1 Checklist).
Results
The database searching yielded a total of 8,671 records. After duplicates were removed, the
titles and abstracts of 3,470 articles were screened. 1,937 records were excluded for being dupli-
cate studies, animal studies, non-RCTs, non-acupuncture studies, not employing a placebo
acupuncture device as the control intervention, not involving a clinical condition or not pub-
lished in English or Chinese. A total of 1533 full-text articles were retrieved for further
Acupuncture Placebo Device
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evaluation, from which 36 were included in this review and 14 in the meta-analysis, respec-
tively (Fig 2).
Description of Included Studies
The 36 included studies were published between 1999 and 2013. Five studies were published in
the Chinese language while the remaining 31 were published in English. Out of the 36 studies,
21 utilised the Streitberger Device [24–44], 13 utilised the Park Device [45–57] and two utilised
the Takakura Device [58,59]. There were 21 studies on pain (musculoskeletal [25–
27,29,30,32,39–41,46,48,52], headache [28,31], or induced pain/analgesia for a medical proce-
dure [33–35,47,51,58,59]), four studies on in-vitro fertilisation (IVF) [24,42,53,54], two studies
on obesity [56,57], two studies on chronic fatigue syndrome [43, 44], and one each on labour
induction [49], tinnitus [50], chronic obstructive pulmonary disease (COPD) [55], Parkinson’s
disease [46], emesis after chemotherapy [36], postmenopausal symptoms [37] and premature
ejaculation [38]. The study sample sizes ranged from 10 to 635 participants, with seven cross-
over studies. The number of needles inserted varied from one to 16, with the treatment dura-
tion ranging from a one-off five minute treatment to a total of 600 minutes of treatment over a
span on 12 weeks. The characteristics of included studies are summarised in Table 1.
Risk of Bias Assessment
The overall risk of bias assessment is summarised in Table 2. In total, 118 “Low risk” assess-
ment, 87 “Unclear risk” and 47 “High risk” were given to all 36 RCTs for seven domains. With
regard to the blinding issue as the particular interest of this research, 69.4% (n = 25) and 61.1%
(n = 22) of studies were judged with low risk for participant blinding and outcome assessment
blinding, respectively. However, only 5.6% (n = 2) of studies which used the Takakura Device
were low risk for blinding of personnel (acupuncturist), while the rest were given judgement of
high risk. This highlights that practitioner blinding is a major issue that needs to be addressed
to enable double-blinded acupuncture clinical studies. When the risk of bias assessment was
Fig 2. Placebo Acupuncture Devices.
doi:10.1371/journal.pone.0140825.g002
Acupuncture Placebo Device
PLOS ONE | DOI:10.1371/journal.pone.0140825 November 4, 2015 5 / 22
Table 1. Characteristics of included studies.
Placebo
Acupuncture
Device
Condition Author, Year Total
sample size
/Dropout/
Analysed
sample size
No. of
acupuncture
points
Treatment
duration
(per
session)/No.
of treatment
sessions/
Total
treatment
duration
Blinding
credibility
reported by the
study
Primary outcome
measures
Signiﬁcant
difference
between
effects of T &
C
Streitberger
Device
Pain (Carpel Tunnel
Syndrome)
Yao, 2012 41/7/34 7 20min/6/6
weeks
NS Carpel Tunnel
Syndrome
Assessment
Questionnaire,
CTSAQ (symptom
and function scales)
NO
Pain (1st
metacarpophalangeal
osteoarthritis pain)
Pariente, 2005 14/0/14
(Crossover)
1 24min/1/ NS NS Regional cerebral
blood ﬂow;
Behavioural factors
(Pain VAS; Holistic
Health Questionnaire,
HCAMQ; Needle
Sensation
Questionnaire, NSQ;
Credibility Rating,
CR)
NO
Pain (Rotator cuff
tendonitis)
Kleinhenz,
1999
52/7/52 12 20min/8/4
weeks
Tested—
successful
Change in Constant-
Murley score
YES (T>C)
Pain (persistent arm
pain due to repetitive
use)
Goldman,
2008
123/5/123 7 to 10 20min/8/4
weeks
Tested—
successful
Self-reported
intensity of pain with
movement on a
10-point numerical
rating scale)
Yes (C>T)
Pain (Chronic shoulder
pain)
Lathia, 2009 20/3/20 8–16 (for
traditional
acu); 7 (for
standard and
sham acu)
20min/12/6
weeks
No Shoulder Pain and
Disability Index
(SPADI)
YES (T>C)
Pain (osteoarthritic pain) White, 2011 147/8/113 average 6
points
20min/8/4
weeks
Tested—
successful
Pain VAS NO
Pain (Knee
osteoarthritis)
Chen, 2013 214/1? 213? 9 20min/12/6–
12 weeks
Tested—
successful
Change in Western
Ontario and
McMaster
Universities
Osteoarthritis Index
(WOMAC);
Secondary outcomes
(Brief Pain Inventory,
BPI; 36-item Short-
Form Health Survey,
SF-36; Patient Global
Impression of
Change; 6-minute
walk test)
NO
Pain (pelvic girdle pain
in pregnant women)
Elden, 2008 115/7/115 13 to 15 30min/12/8
weeks
Tested—
successful
Pain VAS NO
Pain (chronic/stable
pain predominantly from
a single joint (hip or
knee) of known
mechanical aetiology)
White, 2003 37/0/37
(crossover)
average 4
points
20min/4/2
weeks
(washout 2
weeks)
Tested—
successful
Questionnaire
relating to needle
sensation by Park;
Secondary outcomes
(Pain VAS; analgesia
consumption;
Nottingham Health
Proﬁle; Holistic
Health Questionnaire;
Credibility rating)
NO
(Continued)
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Table 1. (Continued)
Placebo
Acupuncture
Device
Condition Author, Year Total
sample size
/Dropout/
Analysed
sample size
No. of
acupuncture
points
Treatment
duration
(per
session)/No.
of treatment
sessions/
Total
treatment
duration
Blinding
credibility
reported by the
study
Primary outcome
measures
Signiﬁcant
difference
between
effects of T &
C
Pain (Pressure pain
threshold in chronic
tension-type headache)
Karst, 2000 39/0/39 max 15 30min/10/5
weeks
Tested—
successful
Consumption of
analgesics; Pain
intensity VAS; site
and duration of
headache attacks;
Clinical Global
Impressions (CGI)
scale; Nottingham
Health Proﬁle;
Everyday-Life-
Questionnaire;
Freiburg
Questionnaire of
Coping with Illness;
von Zerssen
Depression Scale;
Pressure pain
thresholds
NO (for pain
VAS and freq of
headaches);
YES (PPT
signiﬁcantly
increased in
verum acu)
Pain (menstrual- related
migraine)
Linde, 2004 31/3/28 12 30min/9/3
months
Tested—
successful
Number of attacks
per month;
Secondary outcomes
(days with migraine
per month; mean
headache intensity;
amount of headache
medication used)
NO
Induced Pain (human
pain models)
Rebhorn,
2012
50/0/50 8 1h20min/1/1
day
Tested—
unsuccessful
Reduction in mean
pain intensity during
3 minute cold-pressor
test or mean pain
intensity within 10
minutes after
capsaicin injection
NO (Only yes
for relief of
capsaicin
induced pain,
but effects
occurred mainly
in a rating range
that seems
irrelevant to
clinical pain)
Induced Pain (Pressure
pain detection
threshold)
Schliessbach,
2011
45/0/45
(Crossover)
2 5min/1/1 day
(10min
washout)
NS Pressure pain
detection threshold
(PPDT)
NO (between
manual acu and
manual NPSA)
Induced Pain (Pressure
pain detection
threshold)
Schliessbach,
2012
45/0/45
(Crossover)
2 5min/1/1 day
(10min
washout)
NS Pressure pain
detection threshold
(PPDT)
NO
Antiemetic (in
chemotherapy)
Streitberger,
2003
80/0/80 2 20min/2/2
days
Tested—
successful
Number of patients
who either had at
least 1 episode of
vomiting or required
any rescue
antiemetic drugs on
the ﬁrst day of high
dose chemotherapy
and the day after
NO
IVF Anderson,
2010
635/0/635 5 before ET; 4
after ET
30min/2/1
day
NS ongoing pregnancy
rate; live births
NO
IVF Zhang, 2003 140/0/140 4 25min/2/1
day
NS Clinical pregnancy
rate
YES (T>C)
(Continued)
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Table 1. (Continued)
Placebo
Acupuncture
Device
Condition Author, Year Total
sample size
/Dropout/
Analysed
sample size
No. of
acupuncture
points
Treatment
duration
(per
session)/No.
of treatment
sessions/
Total
treatment
duration
Blinding
credibility
reported by the
study
Primary outcome
measures
Signiﬁcant
difference
between
effects of T &
C
Postmenopausal
symptoms and
reproductive hormones
Sunay, 2011a 55/2/53 10 20min/10/5
weeks
NS 11 item Turkish
version of the
Menopause Rating
Scale (MRS);
Secondary (hormone
levels)
YES (T>C)
Premature ejaculation Sunay, 2011b 60/0/60 10 20min/8/4
weeks
NS Intravaginal
ejaculation latency
time (IELT), DSM-IV
TR criteria,
Premature
Ejaculation
Diagnostic Tool
(PEDT)
YES (T>C)
Chronic fatigue
syndrome
Zhang, 2010 45/0/45 10 30min/20/4
weeks
NS SF-20; Chalder
Fatigue Scale
YES (T>C)
Chronic fatigue
syndrome
Zheng, 2011 80/3/77 14–16 30min/20/4
weeks
NS SF-36, Health Utility YES (T>C)
Park Device Pain
(Temporomandibular
myofascial joint pain)
Smith, 2007 27/1/27 1 20min/6/3
weeks
Tested—
successful
Patient functional
perspective VAS;
Pain intensity VAS;
Pain distribution;
Incisor opening and
lateral movement
measurement;
Muscle tenderness;
TMJ tenderness;
Headaches;
Deviation; TMJ
Sounds
NS
Pain (Non-speciﬁc low
back pain)
Kennedy,
2008
48/3/45 8 to 13 30min/3–12/
4–6 weeks
Tested—
successful
Roland and Morris
Disability
Questionnaire,
RMDQ); Pain VAS,
Multidimensional
patient-centred
questionnaire
NO
Pain (Pain intensity from
a myofascial trigger
point)
Chou, 2009 20/0/20 2 19min/1/1
day
NS Numerical pain rating
scale; Changes in
endplate noise
YES (T>C)
Pain (Analgesia during
electromyography)
Smith, 2005 51/0/51 4 5min+-/1/1
day
Tested—
successful
Pain VAS NO
Induced Pain (Thermal
sensation and thermal
pain thresholds)
Downs, 2005 18/0/18
(Crossover)
2 25min/1/3
weeks
Tested—12/18
answered
correctly when
asked what type
of acupuncture
received but may
be correct
guesses as it
was not a
statistically
signiﬁcant
departure
(P = 0.238)
Thermal sensation
and thermal pain
thresholds
NO
Obesity Tong, 2006 41/0/41 12 30min/20/40
days
NS BMI; Hip
circumference:height
ratio
YES (T>C)
(Continued)
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analysed according to the different placebo device controls (Fig 3), studies using the Takakura
Device were judged with low risk for all domains, except for selective reporting which was
judged with unclear risk. Studies involving the Streitberger and Park Devices had similar distri-
bution of high, low and unclear risks of bias. However, it should be noted that there were only
Table 1. (Continued)
Placebo
Acupuncture
Device
Condition Author, Year Total
sample size
/Dropout/
Analysed
sample size
No. of
acupuncture
points
Treatment
duration
(per
session)/No.
of treatment
sessions/
Total
treatment
duration
Blinding
credibility
reported by the
study
Primary outcome
measures
Signiﬁcant
difference
between
effects of T &
C
Obesity Tong, 2010 118/0/118 16 30min/12/5
weeks
NS BMI; Area of adipose
layer of abdomen;
Area of adipose layer
of thighs
YES (T>C)
IVF So, 2009 370/0/370 5 before ET; 4
after ET
25min/2/1
day
Tested—
successful
Overall pregnancy
rate (positive urinary
pregnancy test)
Yes (C>T) for
overall
pregnancy
rates; No for all
other outcomes
IVF So, 2010 226/0/226 4 25min/1/1
day
Tested—
successful
Overall pregnancy
rate (positive urinary
pregnancy test)
NO
Labour induction Modlock, 2010 125/0125 4 30min/1–2/1
day
Tested—
successful
Labour/delivery NO
Tinnitus Rogha, 2011 63/9/54 4 + accesory
acupoints as
needed
NS/10/3
weeks
NS Tinnitus severity
index; Tinnitus
loudness
questionnaire;
Hospital anxiety and
depression scale,
HADS
YES (T>C)
COPD Suzuki, 2012 68/6/62 11 50min/12/12
weeks
NS Breathlessness
(10-point Borg
category ratio scale)
YES (T>C)
Parkinsons Chae, 2009 10/0/10
(crossover)
1 1min/1/ NS Tested—
successful
fMRI scans;
credibility data
(Bang's index)
NO
Takakura
Device
Pain (analgesia after
third molar surgery)
Vase, 2013 101/0/101 5 30min/1/1
day
Tested—
successful
Pain measures
(Perceived pain
intensity and pain
unpleasantness
M-VAS); Expectancy
measures (expected
pain intensity and
pain unpleasantness
M-VAS); perception
of treatment
allocation
YES (T>C)
Induced pain Takakura,
2009
56/0/56
(Crossover)
1 20min/1/1
day (24h
washout)
Tested—
successful
Pain elicited when
electrical stimulation
was applied (numeric
rating scale 0–15);
Secondary outcome
(pain from skin
penetration and the
deqi associated with
needle application,
VAS)
NO
doi:10.1371/journal.pone.0140825.t001
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two studies using the Takakura Device. Nevertheless, the biggest contrast shown in this com-
parison is the ability of the Takakura Device to enable personnel (acupuncturist) blinding.
Treatment Effects
Author-reported differences in therapeutic effects by primary outcome measures are summa-
rised in Table 3. Among all studies, 20 studies (55.6%) reported no significant differences
between verum acupuncture and the placebo devices, 13 studies (36.1%) reported verum acu-
puncture being more effective than placebo, and two studies (5.6%) were in reverse. A consis-
tent trend was found when grouping studies according to the type of placebo devices (Table 3).
Meta-analysis was performed to multiple studies which were of same clinical conditions
and reported same outcome measures (Table 4).
Pain–musculoskeletal. There were 12 studies on musculoskeletal pain, three of which
provided sufficient data of pain intensity measured using a 100mm visual analogue scale
(VAS) or an instrument using a 10-point numerical rating scale (NRS). The VAS rating was
converted to centimetres so that all ratings would be out of 10. Out of the three studies included
in the meta-analysis, one study utilised the Streitberger Device as the control intervention [27]
while two studies utilised the Park Device [46,48]. The overall meta-analysis showed that there
were no significant differences between the verum acupuncture and the placebo devices on
pain intensity VAS (MD: 1.46, 95% CI [-2.92, 5.84]). Subgroup analysis showed that the verum
acupuncture significantly improved pain intensity VAS compared to the Park Device (MD:
3.79, 95% CI [2.91, 4.67]), however the Streitberger Device performed significantly better than
the verum acupuncture (MD: -0.80, 95% CI [-1.54, -0.06]).
Pain–headache. The two included studies on headache evaluated pain intensity using a
10cm VAS [28,31]. Both studies utilised the Streitberger Device as the control intervention.
Meta-analysis showed significant difference, favouring the Streitberger Device (MD: -0.57, 95%
CI [-1.11, -0.04], I2 = 40%).
Pain–induced. Five studies were on induced pain and two on analgesia for a medical pro-
cedure. Among these seven studies, three studies which used the Streitberger Device evaluated
Table 2. Risk of bias assessment of included studies.
Placebo device
used by the
study
Risk or bias
assessment
Random
sequence
allocation
Allocation
concealment
Blinding of
personnel
Blinding of
participants
Blinding of
outcome
assessors
Incomplete
outcome data
Selective
reporting
Streitberger
Device
Low risk 15 (71.4%) 7 (33.3%) 15 (71.4%) 0 (0%) 13 (61.9%) 15 (71.4%) 2 (9.5%)
Unclear risk 5 (23.8%) 14 (66.7%) 5 (23.8%) 0 (0%) 7 (33.3%) 1 (4.8%) 17 (81%)
High risk 1 (4.8%) 0 (0%) 1 (4.8%) 21 (100%) 1 (4.8%) 5 (23.8%) 2 (9.5%)
Park Device Low risk 9 (69.2%) 5 (38.5%) 8 (61.5%) 0 (0%) 7 (53.8%) 10 (76.9%) 0 (0%)
Unclear risk 4 (30.8%) 8 (61.5%) 5 (38.5%) 0 (0%) 6 (46.2%) 0 (0%) 13 (100%)
High risk 0 (0%) 0 (0%) 0 (0%) 13 (100%) 0 (0%) 3 (23.1%) 0 (0%)
Takakura
Device
Low risk 2 (100%) 2 (100%) 2 (100%) 2 (100%) 2 (100%) 2 (100%) 0 (0%)
Unclear risk 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (100%)
High risk 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
All studies Low risk 26 (72.2%) 14 (38.9%) 25 (69.4%) 2 (5.6%) 22 (61.1%) 27 (75%) 2 (5.6%)
Unclear risk 9 (25%) 22 (61.1%) 10 (27.8%) 0 (0%) 13 (36.1%) 1 (2.8%) 32 (88.9%)
High risk 1 (2.8%) 0 (0%) 1 (2.8%) 34 (94.4%) 1 (2.8%) 8 (22.2%) 2 (5.6%)
Note: results are reported as number (and %) of studies received the assessment
doi:10.1371/journal.pone.0140825.t002
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pressure pain threshold (PPT) [33–35]. Standard mean difference (SMD) was calculated
because one of the studies reported PPT as log data [33]. The meta-analysis showed that there
was no significant difference between verum acupuncture and the Streitberger Device in
increasing PPT (SMD: -0.06, 95% CI [-0.32, 0.20], I2 = 0%).
Two of the studies on induced pain also evaluated pain intensity using a 10-point NRS
[34,35]. Both these studies were by the same authors and utilised the Streitberger Device as the
study control intervention. Meta-analysis showed significant difference, favouring the Streit-
berger Device (MD: -1.41, 95% CI [-1.82, -1.00], I2 = 0%).
Obesity. The two studies on acupuncture for treating obesity evaluated body mass index
(BMI) as one of the outcome measures [56,57]. Both studies utilised the Park Device as the
control intervention. The meta-analysis showed significant difference, favouring verum acu-
puncture (MD: 2.50, 95% CI [1.57, 3.42], I2 = 48%).
In-vitro fertilization. There were four studies on acupuncture for IVF–two utilised the
Streitberger Device [24,42] and two applied the Park Device [53,54].
Of the four studies, the two studies which employed the Park Device as the study control
were by the same authors and evaluated overall pregnancy rates. Meta-analysis showed that the
Park Device was significantly more effective than verum acupuncture (RR: 1.24, 95% CI [1.04,
1.47], I2 = 0%). All four studies evaluated clinical pregnancy rates, with the overall meta-analy-
sis showing no significant difference between verum acupuncture and the placebo devices (RR:
1.07, 95% CI [0.84, 1.35], I2 = 62%). Three of the studies evaluated ongoing pregnancy rates
and live birth rates as well [24,53,54]. Meta-analysis showed that there was similar significant
difference in both these outcomes (RR: 1.23, 95% CI [1.04, 1.45], I2 = 0%; and RR: 1.23, 95% CI
[1.03, 1.45], I2 = 0%), favouring the placebo devices. However, when looking at the subgroup
analysis for clinical pregnancy rates, ongoing pregnancy rates and live birth rates, the Park
device also showed significantly better effects than verum acupuncture, but the Streitberger
device was not different to verum acupuncture. It should be noted that there was only one
study using the Streitberger Device [24] that was included in the meta-analysis for ongoing
pregnancy rates and live birth rates.
Adverse events
Out of the 36 included studies, 20 did not mention the evaluation of occurrence of adverse
events, while seven studies noted that no adverse events were observed or recorded. Nine stud-
ies (three using the Park Device [53–55], six using the Streitberger Device [25–27,29,31,39])
noted minor, mild or moderate side effects, with most reporting no significant difference
between groups. One study noted significantly higher incidence of adverse events in the verum
acupuncture group compared to the placebo (Streitberger) device acupuncture group [25].
Fig 3. Risk of bias assessment of included studies. Note: studies were categorised according to the type
of device (P = Park device, S = Streitberger device, T = Takakura device).
doi:10.1371/journal.pone.0140825.g003
Table 3. Reported difference in effects between verum acupuncture and placebo devices.
Placebo
Device
Signiﬁcant difference in
effects (Verum > Placebo)
Signiﬁcant difference in
effects (Placebo > Verum)
No signiﬁcant difference in
effects when compared to
verum acupuncture
Not stated/
Unable to
evaluate
Total number
of studies
Streitberger 7 (33.3%) 1 (4.8%) 13 (61.9%) 0 (0%) 21
Park 5 (38.5%) 1 (7.7%) 6 (46.2%) 1 (7.7%) 13
Takakura 1 (50%) 0 (0%) 1 (50%) 0 (0%) 2
Total 13 (36.1%) 2 (5.6%) 20 (55.6%) 1 (2.8%) 36
doi:10.1371/journal.pone.0140825.t003
Acupuncture Placebo Device
PLOS ONE | DOI:10.1371/journal.pone.0140825 November 4, 2015 12 / 22
However, the authors noted that acupuncture was given immediately after exercise-based phys-
ical therapy and it is therefore impossible to determine the exact cause of the side effects. One
study noted no significant difference between the adverse events that occurred during the run-
in and treatment period; however, there was significant difference (P = 0.004) in “new side
effects attributable to acupuncture only in the treatment period” [27]. Another study also
noted no significant difference in adverse effects, except for a significantly higher sensation of
Deqi in the verum acupuncture group [26]. The total number of adverse events reported by
studies is summarised in Table 5. Overall there were more adverse events occurred in the
Table 4. Treatment effects of meta-analysis results.
Clinical condition (Outcome Measures) Subgroups by Placebo
Device
Number of
studies
Treatment effect meta-analysis results
Pain–Musculoskeletal (Pain intensity using a VAS
scale)
Streitberger 1 (24) MD: -0.80, 95% CI [-1.54, -0.06] Verum
acupuncture < placebo
Park Device 2 (43, 45) MD: 3.79, 95% CI [2.91, 4.67]. I2 = 0% Verum
acupuncture > placebo
All studies 3 (24, 43, 45) MD: 1.46, 95% CI [-2.92, 5.84]. I2 = 0%, I2 = 97%
Pain–Headache (Pain intensity using a VAS
scale)
Streitberger 2 (25, 28) MD: -0.57, 95% CI [-1.11, -0.04]. I2 = 40% Verum
acupuncture < placebo
Pain–Induced (Pressure pain threshold) Streitberger 3 (30–32) SMD: -0.06, 95% CI [-0.32, 0.20]. I2 = 0% Verum
acupuncture = placebo
Pain–Induced (Pain intensity using a 10-point
Numeric Rating Scale)
Streitberger 2 (31, 32) MD: -1.41, 95% CI [-1.82, -1.00], I2 = 0% Verum
acupuncture < placebo
Obesity (Body mass index) Park Device 2 (53, 54) MD: 2.50, 95% CI [1.57, 3.42], I2 = 48% Verum
acupuncture > placebo
In-vitro Fertilisation (Clinical Pregnancy rates) Streitberger Device 2 (21, 39) RR: 0.85, 95% CI [0.49, 1.48], I2 = 79% Verum
acupuncture = placebo
Park Device 2 (50, 51) RR: 1.25, 95% CI [1.03, 1.51], I2 = 0% Verum
acupuncture < placebo
All studies 4 (21, 39, 50,
51)
RR: 1.07, 95% CI [0.84, 1.35], I2 = 62% Verum
acupuncture = placebo
In-vitro Fertilisation (Overall pregnancy rates) Park Device 2 (50, 51) RR: 1.24, 95% CI [1.04, 1.47], I2 = 0% Verum
acupuncture < placebo
In-vitro Fertilisation (Ongoing pregnancy rates) Streitberger Device 1 (21) RR: 1.17, 95% CI [0.92, 1.50] Verum
acupuncture = placebo
Park Device 2 (50, 51) RR: 1.28, 95% CI [1.03, 1.59], I2 = 0% Verum
acupuncture < placebo
All studies 3 (21, 50, 51) RR: 1.23, 95% CI [1.04, 1.45], I2 = 0% Verum
acupuncture < placebo
In-vitro Fertilisation (Live birth rates) Streitberger Device 1 (21) RR: 1.19, 95% CI [0.92, 1.53] Verum
acupuncture = placebo
Park Device 2 (50, 51) RR: 1.26, 95% CI [1.00, 1.59], I2 = 0% Verum
acupuncture < placebo
All studies 3 (21, 50, 51) RR: 1.23, 95% CI [1.03, 1.45], I2 = 0% Verum
acupuncture < placebo
doi:10.1371/journal.pone.0140825.t004
Table 5. Summary of adverse events reported by RCTs.
Studies grouped by Placebo
Device
Total number of events (n
=)
Events in verum acupuncture group
(n =)
Events in placebo acupuncture group
(n =)
Streitberger (10 studies) 338 208 130
Park (4 studies) 450 249 201
Takakura (1 study) 0 0 0
All studies (15 studies) 788 457 331
doi:10.1371/journal.pone.0140825.t005
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verum acupuncture group than in placebo acupuncture group (457 vs 331). The types of
adverse events reported include nausea, dizziness/vertigo, fainting, tiredness/fatigue, drowsi-
ness, headache, chest pain, puncture site itching, pain, bleeding/bruising, agitation, increased
muscle tension/soreness, loss of strength in legs, tearful, inflammation/redness/infection and
facial/cervical blush. The most commonly reported adverse event was acupuncture site itching
among participants who received verum acupuncture and drowsiness among those who
received treatment with the placebo devices. Nevertheless, none of the studies provided further
elaboration regarding the occurrence in adverse events or whether it affected participant or
practitioner blinding.
Blinding credibility
Out of the 36 studies, 15 did not mention credibility blinding [24,32,34,35,37,38,41–
44,46,50,55–57] and one study mentioned that blinding credibility was not evaluated [30].
Twenty studies conducted credibility testing, 19 of which reported successful blinding [25–
29,31,36,37,40,46–49,51–54,58,59] and one of which had unsuccessful blinding [33]; however,
the authors emphasized that incomplete blinding did not affect the results. Table 6 summarises
the number of author-reported blinding credibility testing for each of the placebo devices.
Only two studies which utilised the Streitberger Device [26,42] and five studies which
employed the Park Device [45,48,49,53,57] had sufficient data to enable the calculation of the
BI (Table 7). Using the rule of thumb based on a 0.2 BI cut off point and the “classification
rules of nine blinding scenarios” [60,61], the BI calculation showed that out of the seven stud-
ies, only one study which utilised the Park Device [49] could possibly have had ideal blinding
and clinical effectiveness interpretations. “Unblinded participants” in the verum acupuncture
group (BI>0.2) and “opposite guesses of participants” in the placebo group (BI<-0.2) was
found in the other six individual studies [26,32,45,48,53,54], as well as the pooled BI results of
studies used Streitberger Device [26,32] and that of studies used Park Device [45,48,49,53,54].
Discussion
The three most frequently used placebo devices have been used in RCTs for a variety of conditions,
with pain being the most common condition, followed by IVF. The number of studies somewhat
reflects the length of time that the placebo device has been made available, with the majority of the
studies using the Streitberger Device and the least studies using the Takakura Device.
The ideal acupuncture placebo device should be fully inert and support participant blinding
to reduce placebo effects. In terms of the efficacy, a recent meta-analysis of individual patient
data of acupuncture RCTs for pain found that, there were differences in effect sizes among tri-
als with different control conditions. This implies that trials used non-penetrating needle con-
trol had overall larger effect size compared to those using penetrating needle sham control
[62]. However, this review only evaluated RCTs of pain conditions. The meta-analyses of our
review showed that there were no significant differences between the therapeutic effects by the
Table 6. Author reported blinding credibility testing.
Placebo device used
in the study
Blinding credibility
tested–successful (n)
Blinding credibility tested–
unsuccessful (n)
Blinding credibility
not tested (n)
No mention of blinding
credibility testing (n)
Total
(n)
Streitberger 9 1 1 10 21
Park 8 0 0 5 13
Takakura 2 0 0 0 2
All studies 19 1 1 15 36
doi:10.1371/journal.pone.0140825.t006
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Streitberger Device when compared to verum acupuncture. With regard to the Park Device,
the meta-analyses showed that verum acupuncture was significantly more effective, except in
the cases of IVF, where the Park Device were significantly more effective. The overall analysis
does not support the notion of these devices being an inert control intervention, although it
may be debated that the Park Device shows more promise compared to the Streitberger Device.
However, most studies noted that the placebo devices may not be a completely inert interven-
tion Nevertheless, the number studies which were included in the analyses was small and these
studies were of poor quality as evaluated by the risk of bias assessment and should be inter-
preted with caution. Furthermore, if a no treatment (waiting list) group was included in these
RCTs, the difference between the placebo group and the no treatment group may further
assist in evaluating the validity of placebo intervention. Unfortunately, only one RCT [42]
employed a waiting list group as the third arm. Further research should take this point into
consideration.
Table 7. Blinding index.
Placebo
device
Author,
year
Guess
real in
AC
group
Unsure
in AC
group
Guess
placebo
in AC
group
Guess
real in
CT
group
Unsure
in CT
group
Guess
placebo
in CT
group
VBI SBI VBI vs SBI Clinical effectiveness
interpretations
Streitberger Pariente
2005
14 0 0 11 0 3 1.00 -0.57 Unblinded
vs Opposite
guess
Possible that patients
tend to have wishful
thinking, weak
treatment and strong
placebo effect, or any
treatment administered
is perceived as real
treatment
Elden
2008
35 18 1 35 15 2 0.63 -0.63 Unblinded
vs Opposite
guess
All
studies
49 18 1 46 15 5 0.71 -0.62 Unblinded
vs Opposite
guess
Park So 2009 111 59 15 95 61 29 0.52 -0.36 Unblinded
vs Opposite
guess
Possible that patients
tend to have wishful
thinking, weak
treatment and strong
placebo effect, or any
treatment administered
is perceived as real
treatment
Modlock
2010
8 26 5 5 28 7 0.08 0.05 Random
guess vs
Random
guess
Ideal scenario
So 2010 79 28 6 55 32 26 0.65 -0.26 Unblinded
vs Opposite
guess
Possible that patients
tend to have wishful
thinking, weak
treatment and strong
placebo effect, or any
treatment administered
is perceived as real
treatment
Chae
2009
9 0 1 7 2 1 0.80 -0.60 Unblinded
vs Opposite
guess
Kennedy
2008
23 0 0 22 0 0 1.00 -1.00 Unblinded
vs Opposite
guess
All
studies
230 113 27 184 123 63 0.55 -0.33 Unblinded
vs Opposite
guess
Note: AC: acupuncture; CT: control; BI: blinding indext; VBI: blinding index of real acupuncture group; SBI: blinding index of sham acupuncture group. The
interpretation of BI results is based on the 9 blinding scenarios introduced by Freed et al 2014 [61]
doi:10.1371/journal.pone.0140825.t007
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Out of the 16 studies that reported adverse events, only one study noted significantly more
adverse events by verum acupuncture when compared to the Streitberger Device [25]. All other
reported adverse events were deemed minor, with no significant difference between verum acu-
puncture and any of the placebo devices. Generally, verum acupuncture seemed to have more
incidences of most types of adverse events reported. However, it is interesting to note that
despite being non-penetrating devices, there were still adverse events reported among partici-
pants in the placebo groups. It should be noted there were no reports of pain as an adverse
event caused by the Park Device, while it was fairly common with the Streitberger Device. This
may be a difference in reporting by authors, as there were reports of ‘puncture site itching’ by
the Park Device instead.
When blinding credibility was reported, most authors claimed successful blinding. How-
ever, several studies reported blinding credibility vaguely, stating that no participants were able
to distinguish between verum and placebo acupuncture instead of reporting the exact number
of participants guessing the intervention correctly or incorrectly. In our study, the BI calculated
for the seven studies did not strongly support the notion of successful blinding. Only one study
which utilised the Park Device [49] could possibly have had ideal blinding scenario. However,
the pooled BI results of Streitberger Device and Park Device were not indicating an ideal blind-
ing scenario. While BI could not be calculated for the Takakura Device, the authors of the two
studies reported successful participant blinding and it was the only device which was able to
support practitioner blinding as well. Recently, Moroz et al. used BI to evaluate the effective-
ness of blinding of 54 acupuncture RCTs [63]. It was found that the studies (n = 22) using
three non-penetrating needles as placebo control (Streitberger, Park, and Takakura devices)
achieved effective blinding of participants. However, this study did not perform subgroup anal-
ysis to investigate the difference among these three devices [63]. In addition, after the comple-
tion of our research, a systematic review assessing non-penetrating placebo needles was
published [64], which concluded that non-penetrating placebo needles achieved effective
blinding. Unfortunately the number of included studies was very small (n = 5), and the authors
did not differentiate three types placebo devices in their analysis.
Originally, BI was demonstrated with pharmacological studies [23], and recently it has been
used in acupuncture studies to assess the blinding credibility [65–67]. Since BI is directly inter-
preted as the percentage of un-blinding beyond chance, it can capture different behaviours in
different arms. Particularly, BI may reveal the ‘wishful thinking’ or ‘lack of idea about control
treatment’ scenario in which patients believe they are on active treatment. These scenarios are
common in acupuncture studies [60]. In fact, the interpretation of BI can be subjective because
this may represent complete blinding or complete un-blinding in opposite directions. The cut-
off points, whether it is 0.2 or 0.3 is also somehow subjective. Further research using BI should
carefully address such complexity.
When comparing the design of the three placebo acupuncture devices, the Streitberger has
been the most widely used and validated. Despite being shown to be successful in participant-
blinding, it does not solve the problem of practitioner- or double-blinding. Furthermore, con-
cerns were raised regarding the difficulty in applying the device on acupuncture points in cer-
tain areas such as the fingers, toes and scalp [14]. Also, it does not allow for a variation in
needle manipulation or direction of insertion. Furthermore, it was stated that the needle sterili-
sation may be compromised as the needle penetrates through the dressing plaster [15]. In one
study, practitioners complained about the limitation of choosing acupuncture points and the
need to apply acupuncture using the ring and dressing plaster so that real and placebo acu-
puncture appeared the same [27]. Another study noted that the use of the ring and plaster may
increase discomfort in participants and limit the type of needling techniques [41].
Acupuncture Placebo Device
PLOS ONE | DOI:10.1371/journal.pone.0140825 November 4, 2015 16 / 22
The Park Device does not support double-blinding either and shares the limitation of the
Streitberger Device where there is difficulty in applying the device at points located on the toes
[49], fingers and scalp. However, the added oversized guide tube and silicon flange in the Park
Device prevent the compromise of needle sterilization and is said to allow the practitioner to
perform manipulation as necessary [16].
The Takakura Device is reported to be applicable at all acupuncture points, including those
on the toes, fingers and scalp and the practitioner is able to alter direction of needle insertion
by moving the lower end of the guide tube [68]. Being the newest among the three devices, the
Takakura Device is mostly praised for being the first placebo acupuncture device to enable
practitioner blinding. This is because of the soft material stuffing that Takakura and colleagues
added into the guide tube of the device, to ensure that the practitioner experiences the same
sensations when inserting verum acupuncture needles or the blunt-tipped non-penetrating
needle. However, in order to ensure a uniform appearance and insertion depth, the Takakura
Device is made with a stopper to limit the depth of needle insertion. While a variety of needle
lengths differentiated by colour coded handles can be easily produced, it may increase the costs
of production. Furthermore, researchers using the Takakura Device would not have the choice
of needles, as they would when using the Streitberger or Park Devices. Upon examination of
the Takakura Device, we have noted that the soft stuffing used is quite firm, thereby causing
the practitioner to feel the same amount of tension when needling with a real needle or with
the placebo device. However, this tension is stronger than what a practitioner would normally
experience with verum acupuncture. Both the stuffing and stopper in the Takakura Device also
limit the ability for needle manipulation and the ability of the practitioner to feel Deqi sensation
during needling.
In all cases of placebo acupuncture devices, unblinding could occur if there was any bleeding
cause by verum acupuncture. However, in this review, it was noted that there were several
cases of bleeding or bruising by the Streitberger Device as well [25,26,31,39]. Another concern
is with regard to the stimulation or physiological effects from the touching of the skin by the
blunt-tipped needles. In efforts to overcome this, Takakura et al. designed a modified “no
touch” version of the Takakura Device, whereby the “the tip of the placebo needle does not
penetrate through the stuffing to come in contact with the skin [69]. However, a validation
study showed that this device did not support participant blinding and was, therefore, not suit-
able for double-blind testing of acupuncture effects [69,70].
With the improvements in the Takakura Device, it appears that practitioner-blinding is also
made possible. However, traditional acupuncture (notwithstanding variation in practice based
on country or school of thought) requires the practitioner to be able to insert the needle at vari-
ous locations with different angles, depth and manipulation. Minimising the size of the flange
may reduce concerns regarding the discomfort felt by participants and altering the flange to
include a pivot device may overcome the issue of needling at various locations and angles. In
addition, the stopper used in the Takakura Device may be omitted and the current stuffing
could be replaced with a softer material to enable better control of the depth of insertion and
manipulation of needles. An alternative would be to incorporate the telescoping blunt-tipped
needle with added stuffing in the telescoping handle to the Takakura Device so that the practi-
tioner may still experience the same sensation as the verum acupuncture.
From this review, aside from highlighting the need for placebo controls to be inert and sup-
port blinding, it should be noted that the placebo controls should also enable the real interven-
tion to be performed as per normal and for the placebo to mimic its appearance and experience
felt by practitioners and participants. Furthermore, with acupuncture studies, the expectation
of creating an inert placebo control is related to the assumption that acupuncture is indeed an
efficacious treatment.
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Previous studies on acupuncture mechanism suggest that acupuncture effects are due to
physiological response and nervous activation by needle insertion [71]. Therefore, non-pene-
trating placebo devices were said to be the potential solution to this issue. However, Dorsher
argues that true “sham” needles should produce a sensation which mimics that of verum acu-
puncture [72]. He further claims that these devices are likely to produce no significant differ-
ence in outcomes when compared to verum acupuncture, as seen with some of the meta-
analyses in this study. Although it has been acknowledged that these non-penetrating acupunc-
ture placebo devices are not fully inert, they seem to have been fairly successful in participant-
blinding and are considered the current best available form of acupuncture placebo control.
Our research found that there is yet insufficient evidence to identify “the best” placebo
device from among the three devices which have been evaluated in this review. As the current
state of evidence of the efficacy of acupuncture remains unclear, it is still debatable whether it
is possible, or even necessary, to achieve a placebo control for the intervention; or whether it
would be more beneficial to evaluate the effectiveness of acupuncture in comparison to other
therapies instead [73].
It should be noted that other confounding factors, e.g. participant expectation/experience,
and practitioner-participant interaction, may affect therapeutic effect and blinding [74]. In our
review, the majority of included studies failed to clearly report on whether these issues were
considered and what precautions were taken. Future RCTs should report more details on how
much information was given to participants regarding the interventions, whether or not partic-
ipants were acupuncture naive, and how practitioner-participant interactions were limited/
encouraged.
Conclusions
Based on the meta-analyses, neither the Streitberger Device nor the Park Device seemed to be
an adequate inert control for acupuncture RCTs, while none of the studies which utilised the
Takakura Device were included in the meta-analyses to allow for comparison. Author-reported
blinding credibility apparently showed that all three placebo devices were mostly successful in
participant blinding; however, when comparing the blinding index, only one study, which uti-
lised the Park Device, was noted to have an ideal blinding scenario. To date, the Takakura
Device is the only device that seemed to enable practitioner blinding and may therefore seem
to have more promise as a suitable placebo control. With these in mind, more rigorous studies
are needed to further evaluate its effects when compared to verum acupuncture and its blinding
credibility. There are limitations with each of the devices and more research is needed to
inform the future development of an improved placebo device for future acupuncture RCTs.
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